Tools   Select Another Resource Report Type

http://www.scienceexchange.com/facilities/university-health-network

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on April 19,2024. Portal, Core facility

Proper citation: University Health Network Labs and Facilities (RRID:SCR_012483) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/medros-inc

An Core facility

Proper citation: Medros (RRID:SCR_012400) Copy   

•   Source: SciCrunch Registry

https://oligofactory.com/

Provides oligonucleotides. Synthesizes custom DNA/RNA oligonucleotides for scientific and therapeutic communities.

Proper citation: Oligo Factory (RRID:SCR_012567) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/duke-university

An Portal, Core facility

Proper citation: Duke University Labs and Facilities (RRID:SCR_012445) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/am-biotechnologies-llc

AM Biotechnologies develops DNA-based affinity agents called thioaptamers using unique chemistries and a proprietary bead-based selection process. Antibodies are currently the most widely-used affinity agents but they are produced in animals; are easily degraded; are expensive to produce; and suffer from batch-to-batch variability. In contrast, thioaptamers are chemically synthesized; they are stable in ambient environments with very long shelf life; and are rapidly produced in large quantities with easy quality control. We solve the problems associated with antibodies while delivering the same functionality. Thioaptamers can be substituted for antibodies in virtually any application. We can develop thioaptamer affinity agents for your targets using our bead-based development service. AM also offers DNA thiophosphoramidite reagents via a strategic partnership with Glen Research Corporation and the RNA thiophosphoramidites are near market introduction. These unique reagents are used to synthesize thioaptamers and are also highly useful for providing in vivo stability and increased potency in RNAi applications. The company was founded in 2006 and is primarily owned by two corporations. It has been awarded numerous SBIR grants and has also benefited from over $10M of prior university research into its technologies. Importantly, all of our technologies have freedom to operate.

Proper citation: AM Biotechnologies (RRID:SCR_012568) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/trevigen

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on April 19,2024. Trevigen Cell Assays (TCA), a division of Trevigen, Inc., was established in 2008 to conduct contract research work for the pharmaceutical, biotechnology, government and academic segments of the medical research market. TCA specializes in designing and conducting assays for lead compounds and genotoxic screening based on DNA damage and repair as well as cancer cell behavior.

Proper citation: Trevigen Cell Assays (RRID:SCR_012449) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/university-of-nebraska-medical-center

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on April 16,2024. Portal, core facility.

Proper citation: University of Nebraska Medical Center Labs and Facilities (RRID:SCR_012451) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/suny-at-stony-brook

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on April 23,2024. Portal, Core facility

Proper citation: SUNY at Stony Brook Labs and Facilities (RRID:SCR_012455) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/advanced-bioscience-laboratories

Advanced BioScience Laboratories, Inc (ABL) is a leading contract research and manufacturing organization, partnering with our clients to advance their vaccine and therapeutic development programs. Our unique combination of preclinical and clinical services provide the tools to address the scientific challenges encountered during any stage of product development. For preclinical studies, we utilize immunological, molecular, and cell-based assay platforms for candidate selection. We offer proof-of-concept in vivo studies with preclinical immunomonitoring and efficacy and potency testing. Once a clinical candidate is identified, ABL''s in-house cGMP suites are designed for single-use technologies accommodating a wide range of products, including mammalian- and microbial-based protein therapeutics as well as viral vectors and vaccines.

Proper citation: Advanced BioScience Laboratories (RRID:SCR_012576) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/university-of-rochester

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on April 16,2024. Portal, Core facility

Proper citation: University of Rochester Labs and Facilities (RRID:SCR_012454) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/cornell-university

An Portal, Core facility

Proper citation: Cornell University Labs and Facilities (RRID:SCR_012457) Copy   

•   Source: SciCrunch Registry

https://www.tglabs.com/home.html

TG Labs Company, located in Colorado, has two divisions Technical division and Industrial division. Technical Division operates scientific, medical and chemical discovery laboratory in Englewood, Colorado. This division also develops special devices, equipment and processes for the medical, chemical and environmental industries. We offer proven solutions from concept through full scale production, including regulatory standards.

Proper citation: TG Labs (RRID:SCR_012581) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/the-ohio-state-university

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on April 22, 2024. Portal, Core facility

Proper citation: Ohio State University Labs and Facilities (RRID:SCR_012462) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/ohio-university

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on May 14,2024. Portal, Core facility

Proper citation: Ohio University Labs and Facilities (RRID:SCR_012461) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/biotrend-chemikalien-gmbh-cologne

After more than a decade of experience in the sale and marketing of research products for Life Science Research, Werner Hassler, Switzerland and Gunther Jaeger, Germany founded the Cologne based BIOTREND Chemikalien GmbH in May 1988. BIOTREND was instigated in order to meet the growing demand from customers for an independent and technologically orientated distribution facility offering high quality, yet cost-effective products for biochemical, immunochemical and pharmaceutical research. Through our innovative strength we are not only providing our customers a vast product range, but also a high quality, first-class service package. At present we offer more than 90.000 products that have successfully been implemented not only in the drug discovery market, but also in cancer research as well as other scientific fields.

Proper citation: BIOTREND Chemikalien GmbH (RRID:SCR_012423) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/acrobiosystems

ACRObiosystems is aiming to be one of the leading bulk proteins/mAb products and biologics research service providers. we offer exceptional speed without compromising product quality.

Proper citation: ACRObiosystems (RRID:SCR_012550) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/kinexus-bioinformatics-corporation

Core is a systems proteomics/bioinformatics company that conducts in-house signal transduction research. Core services also enable for identification and validation of biomarkers, drug targets and therapeutic compounds.

Proper citation: Kinexus Bioinformatics Corporation (RRID:SCR_012553) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/genetica-dna-laboratories

Genetica DNA Laboratories is a full service DNA testing laboratory providing a wide range of DNA testing services for over two decades worldwide. Genetica has been accreadited by AABB for DNA parentage testing for almost 20 years.

Proper citation: Genetica DNA Laboratories (RRID:SCR_012558) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/memorial-sloan-kettering-cancer-center

Memorial Sloan Kettering Cancer Center is committed to exceptional patient care, leading edge research, and superb educational programs. Close collaboration between our physicians and scientists provides patients with care available to discover more effective strategies to prevent, control, and ultimately cure cancer. Provides researchers with Organic Synthesis Core Facility, High-Throughput Drug Screening Facility and Antibody and Bioresource Core Facility.

Proper citation: Memorial Sloan-Kettering Cancer Center Labs and Facilities (RRID:SCR_012559) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/irvine-scientific

A commercial contract research organization that mentions embryo culture media for IVF procedures and cell therapy on their website.

Proper citation: Irvine Scientific (RRID:SCR_012440) Copy   

•   Source: SciCrunch Registry